12 Total results for product and free and sample content found
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Janssen has returned the rights to an obesity/diabetes drug to originator Hanmi, after Phase II studies failed to achieve glycemic control targets and reflecting development difficulties in the sector. This is the fourth time for the Korean firm to face a U-turn of licensed out compounds.
Medtech Insight: 世界の医療機器・医療技術の最新情報
The American Diabetes Association held their annual meeting virtually from June 12-16, 2020. Catch up with critical event updates and the latest developments, groundbreaking research and scientific advances from the editors and analysts at Medtech Insight, who were covering the event live and reporting on the vital medtech news and science to come out of the 80th Scientific Sessions.
Topic diabetes
Meddevicetracker: 医療機器の市場調査分析・データベース
Keep your finger on the pulse of digital health technologies with Meddevicetracker’s “Digital Health: Diabetes Apps and Virtual Coaching” report. An extract of this market analysis, covering smartphone apps, continuous glucose monitoring devices, and virtual diabetes coaching, is now available.
Topic digital-health diabetes
Generics Bulletin: ジェネリック＆バイオシミラーニュース
The US FDA has slapped Biocon with a dozen observations over three units at its insulin manufacturing facility in Malaysia, but the Indian biotech firm says the problems can be remedied quickly and that US launch plans are on track for its insulin product glargine challenging French drug-maker Sanofi’s multi-billion-dollar Lantus.
Topic fda diabetes biopharmaceutical
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
AstraZeneca’s head of R&D spoke to Scrip about the outstanding results for dapagliflozin in heart failure regardless of diabetes status.
Topic company-analysis diabetes
Medtech Insight: 世界の医療機器・医療技術の最新情報
Changes are being made to the UK’s Accelerated Access Collaborative to help streamline access to ground-breaking medicines and diagnostic tools in areas like dementia, diabetes and cancer.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.
Topic Diabetes
Datamonitor Healthcare: 医療用医薬品の市場調査レポート
These reports includes 20-year forecasts of prevalent type 1 and type 2 diabetes cases segmented by age and gender, and drug-treated diabetes, segmented by treatment type.
Topic diabetes
No Records Found
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
お問い合わせ先
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。
Eメール：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。
